MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/eurheartj/ehae021

Медицинская библиотека · European heart journal · 2024

Electrical storm treatment by percutaneous stellate ganglion block: the STAR study.

Savastano Simone, Baldi Enrico, Compagnoni Sara, Rordorf Roberto, Sanzo Antonio, Gentile Francesca Romana, Dusi Veronica, Frea Simone, Gravinese Carol, Cauti Filippo Maria, Iannopollo Gianmarco, De Sensi Francesco, Gandolfi Edoardo, Frigerio Laura, Crea Pasquale, Zagari Domenico, Casula Matteo, Sangiorgi Giuseppe, Persampieri Simone, Dell'Era Gabriele, Patti Giuseppe, Colombo Claudia, Mugnai Giacomo, Notaristefano Francesco, Barengo Alberto, Falcetti Roberta, Perego Giovanni Battista, D'Angelo Giuseppe, Tanese Nikita, Currao Alessia, Sgromo Vito, De Ferrari Gaetano Maria, STAR study group

Наблюдательное исследованиеМногоцентровое исследованиеСтатьяПеревод в очереди

Аннотация

BACKGROUND AND AIMS: An electrical storm (ES) is a clinical emergency with a paucity of established treatment options. Despite initial encouraging reports about the safety and effectiveness of percutaneous stellate ganglion block (PSGB), many questions remained unsettled and evidence from a prospective multicentre study was still lacking. For these purposes, the STAR study was designed.

METHODS

This is a multicentre observational study enrolling patients suffering from an ES refractory to standard treatment from 1 July 2017 to 30 June 2023. The primary outcome was the reduction of treated arrhythmic events by at least 50% comparing the 12 h following PSGB with the 12 h before the procedure. STAR operators were specifically trained to both the anterior anatomical and the lateral ultrasound-guided approach.

RESULTS

A total of 131 patients from 19 centres were enrolled and underwent 184 PSGBs. Patients were mainly male (83.2%) with a median age of 68 (63.8-69.2) years and a depressed left ventricular ejection fraction (25.0 ± 12.3%). The primary outcome was reached in 92% of patients, and the median reduction of arrhythmic episodes between 12 h before and after PSGB was 100% (interquartile range -100% to -92.3%). Arrhythmic episodes requiring treatment were significantly reduced comparing 12 h before the first PSGB with 12 h after the last procedure [six (3-15.8) vs. 0 (0-1), P < .0001] and comparing 1 h before with 1 h after each procedure [2 (0-6) vs. 0 (0-0), P < .001]. One major complication occurred (0.5%).

CONCLUSIONS

The findings of this large, prospective, multicentre study provide evidence in favour of the effectiveness and safety of PSGB for the treatment of refractory ES.

Для цитирования: Savastano Simone, Baldi Enrico, Compagnoni Sara, Rordorf Roberto, Sanzo Antonio, Gentile Francesca Romana, Dusi Veronica, Frea Simone, Gravinese Carol, Cauti Filippo Maria, Iannopollo Gianmarco, De Sensi Francesco, Gandolfi Edoardo, Frigerio Laura, Crea Pasquale, Zagari Domenico, Casula Matteo, Sangiorgi Giuseppe, Persampieri Simone, Dell'Era Gabriele, Patti Giuseppe, Colombo Claudia, Mugnai Giacomo, Notaristefano Francesco, Barengo Alberto, Falcetti Roberta, Perego Giovanni Battista, D'Angelo Giuseppe, Tanese Nikita, Currao Alessia, Sgromo Vito, De Ferrari Gaetano Maria, STAR study group. Electrical storm treatment by percutaneous stellate ganglion block: the STAR study.. European heart journal. 2024. DOI: 10.1093/eurheartj/ehae021.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.